[HTML][HTML] Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
JE Ying, LM Zhu, BX Liu - World journal of gastroenterology: WJG, 2012 - ncbi.nlm.nih.gov
In the past 15 years, we have seen few therapeutic advances for patients with pancreatic
cancer, which is the fourth leading cause of cancer-related death in the United States …
cancer, which is the fourth leading cause of cancer-related death in the United States …
Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
JE Ying, LM Zhu, BX Liu - World Journal of Gastroenterology, 2012 - europepmc.org
In the past 15 years, we have seen few therapeutic advances for patients with pancreatic
cancer, which is the fourth leading cause of cancer-related death in the United States …
cancer, which is the fourth leading cause of cancer-related death in the United States …
[引用][C] Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
JE Ying - World J Gastroenterol, 2012 - cir.nii.ac.jp
[HTML][HTML] Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
JE Ying, LM Zhu, BX Liu - World Journal of Gastroenterology, 2012 - wjgnet.com
In the past 15 years, we have seen few therapeutic advances for patients with pancreatic
cancer, which is the fourth leading cause of cancer-related death in the United States …
cancer, which is the fourth leading cause of cancer-related death in the United States …
Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
JE Ying, LM Zhu, BX Liu - World journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
In the past 15 years, we have seen few therapeutic advances for patients with pancreatic
cancer, which is the fourth leading cause of cancer-related death in the United States …
cancer, which is the fourth leading cause of cancer-related death in the United States …
[引用][C] Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
JE Ying - World Journal of Gastroenterology, 2012 - cir.nii.ac.jp
Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
JE Ying, LM Zhu, BX Liu - World Journal of Gastroenterology, 2012 - europepmc.org
In the past 15 years, we have seen few therapeutic advances for patients with pancreatic
cancer, which is the fourth leading cause of cancer-related death in the United States …
cancer, which is the fourth leading cause of cancer-related death in the United States …